Merck is trading at $132.35, with a -11.50% change and no clear company-specific announcement, earnings release, or regulatory event explaining the after-hours decline. - Recent positive melanoma-trial news was published earlier and does not directly explain the move. - The broader market was higher, so the decline does not appear aligned with overall risk-on sentiment. - Sharp after-hours activity followed a $149.54 regular-session close on August 27, 2026.